{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:56:03Z","timestamp":1785768963911,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Tianjin Science and Technology Support Program","award":["NO. 14CZDSY0005"],"award-info":[{"award-number":["NO. 14CZDSY0005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10529-018-2578-4","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T07:43:58Z","timestamp":1529307838000},"page":"1209-1218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Stable expression of infliximab in CRISPR\/Cas9-mediated BAK1-deficient CHO cells"],"prefix":"10.1007","volume":"40","author":[{"given":"Zhi","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Cun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"2578_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"MF And","year":"2001","unstructured":"And MF, Maini RN (2001) Anti-TNF\u03b1 therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19:163\u2013196","journal-title":"Annu Rev Immunol"},{"key":"2578_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.sbi.2015.03.002","volume":"32","author":"K B\u00fcssow","year":"2015","unstructured":"B\u00fcssow K (2015) Stable mammalian producer cell lines for structural biology. Curr Opin Struct Biol 32:81\u201390","journal-title":"Curr Opin Struct Biol"},{"key":"2578_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF et al (2010) Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med 362:1383","journal-title":"N Engl J Med"},{"key":"2578_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1862-1_10","volume-title":"Genome engineering using CRISPR-Cas9 system","author":"L Cong","year":"2015","unstructured":"Cong L, Zhang F (2015) Genome engineering using CRISPR-Cas9 system. Springer, New York"},{"key":"2578_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrc883","volume":"2","author":"S Cory","year":"2002","unstructured":"Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647","journal-title":"Nat Rev Cancer"},{"key":"2578_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2578_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/bit.24841","volume":"110","author":"P Datta","year":"2013","unstructured":"Datta P, Linhardt RJ, Sharfstein ST (2013) An \u2018omics approach towards CHO cell engineering. Biotechnol Bioeng 110:1255\u20131271","journal-title":"Biotechnol Bioeng"},{"key":"2578_CR8","first-page":"334","volume":"150","author":"JM Fragoso","year":"2014","unstructured":"Fragoso JM, Vargas AG, Jim\u00e9nez MS, Reyes Hern\u00e1ndez OD, Ram\u00edrez BJ (2014) Tumor necrosis factor alpha (TNF-\u03b1) in autoimmune diseases (AIDs): molecular biology and genetics. Gaceta M\u00e9dica De M\u00e9xico 150:334","journal-title":"Gaceta M\u00e9dica De M\u00e9xico"},{"key":"2578_CR9","first-page":"76","volume":"8","author":"SE Gabriel","year":"2014","unstructured":"Gabriel SE (2014) The epidemiology of rheumatoid arthritis. Am J Public Health Nations Health 8:76\u201379","journal-title":"Am J Public Health Nations Health"},{"key":"2578_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach C, Barbas RC (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 31:397\u2013405","journal-title":"Trends Biotechnol"},{"key":"2578_CR11","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1073\/pnas.88.16.6961","volume":"88","author":"DM Hockenbery","year":"1991","unstructured":"Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961\u20136963","journal-title":"Proc Natl Acad Sci USA"},{"key":"2578_CR12","first-page":"40","volume":"103","author":"KP Jayapal","year":"2007","unstructured":"Jayapal KP, Wlaschin KF, Hu WS, Yap MGS (2007) Recombinant protein therapeutics from CHO cells\u201420\u00a0years and counting. Chem Eng Prog 103:40\u201347","journal-title":"Chem Eng Prog"},{"key":"2578_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00253-009-1903-1","volume":"83","author":"SH Kim","year":"2009","unstructured":"Kim SH, Lee GM (2009) Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments. Appl Microbiol Biotechnol 83:639","journal-title":"Appl Microbiol Biotechnol"},{"key":"2578_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/btpr.2115","volume":"31","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim YG, Lee GM (2015) Effect of Bcl-xL overexpression on sialylation of Fc-fusion protein in recombinant Chinese hamster ovary cell cultures. Biotechnol Prog 31:1133\u20131136","journal-title":"Biotechnol Prog"},{"key":"2578_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.tcb.2016.07.002","volume":"26","author":"MPA Luna-Vargas","year":"2016","unstructured":"Luna-Vargas MPA, Chipuk JE (2016) Physiological and pharmacological control of BAK, BAX, and beyond. Trends Cell Biol 26:906\u2013917","journal-title":"Trends Cell Biol"},{"key":"2578_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10616-014-9778-0","volume":"67","author":"H Miki","year":"2015","unstructured":"Miki H, Takagi M (2015) Design of serum-free medium for suspension culture of CHO cells on the basis of general commercial media. Cytotechnology 67:689\u2013697","journal-title":"Cytotechnology"},{"key":"2578_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jbspin.2016.07.007","volume":"83","author":"E Minichiello","year":"2016","unstructured":"Minichiello E, Semerano L, Boissier MC (2016) Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint Bone Spine 83:625\u2013630","journal-title":"Joint Bone Spine"},{"key":"2578_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S (1997) Apoptosis by death factor. Cell 88:355\u2013365","journal-title":"Cell"},{"key":"2578_CR19","first-page":"29","volume":"27","author":"N Rychlick","year":"2018","unstructured":"Rychlick N (2018) Biosimilars for rheumatoid arthritis: don\u2019t count them out quite yet. Manag Care 27:29","journal-title":"Manag Care"},{"key":"2578_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/gtc.12183","volume":"20","author":"RF Shearer","year":"2015","unstructured":"Shearer RF, Saunders DN (2015) Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes Cells 20:1\u201310. \n                    https:\/\/doi.org\/10.1111\/gtc.12183","journal-title":"Genes Cells"},{"key":"2578_CR21","first-page":"1218","volume":"15","author":"S Singh","year":"2017","unstructured":"Singh S, Andersen NN, Andersson M, Loftus EV Jr, Jess T (2017) Comparison of infliximab and adalimumab in biologic-naive patients with ulcerative colitis: a Nationwide Danish Cohort Study Clinical Gastroenterology & Hepatology the Official Clinical Practice. J Am Gastroenterol Assoc 15:1218\u20131225","journal-title":"J Am Gastroenterol Assoc"},{"key":"2578_CR22","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, Mcinnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"2578_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"Wei MC et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727\u2013730","journal-title":"Science"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10529-018-2578-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-018-2578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-018-2578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T23:04:59Z","timestamp":1560812699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10529-018-2578-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s10529-018-2578-4","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}